A Strategy for Suppressing Macrophage-mediated Rejection in Xenotransplantation

Transplantation. 2020 Apr;104(4):675-681. doi: 10.1097/TP.0000000000003024.

Abstract

Although xenografts are one of the most attractive strategies for overcoming the shortage of organ donors, cellular rejection by macrophages is a substantial impediment to this procedure. It is well known that macrophages mediate robust immune responses in xenografts. Macrophages also express various inhibitory receptors that regulate their immunological function. Recent studies have shown that the overexpression of inhibitory ligands on porcine target cells results in the phosphorylation of tyrosine residues on intracellular immunoreceptor tyrosine-based inhibitory motifs on macrophages, leading to the suppression of xenogenic rejection by macrophages. It has also been reported that myeloid-derived suppressor cells, a heterogeneous population of immature myeloid cells, suppress not only NK and cytotoxic T lymphocyte cytotoxicity but also macrophage-mediated cytotoxicity. This review is focused on the recent findings regarding strategies for inhibiting xenogenic rejection by macrophages.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • CD47 Antigen / genetics
  • CD47 Antigen / immunology
  • CD47 Antigen / metabolism
  • Graft Rejection / genetics
  • Graft Rejection / immunology
  • Graft Rejection / metabolism
  • Graft Rejection / prevention & control*
  • Graft Survival*
  • Heterografts / immunology
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Immunity, Cellular*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Macrophages / immunology*
  • Macrophages / metabolism
  • Myeloid-Derived Suppressor Cells / immunology
  • Myeloid-Derived Suppressor Cells / metabolism
  • Myeloid-Derived Suppressor Cells / transplantation
  • Phagocytosis
  • Pulmonary Surfactant-Associated Protein D / genetics
  • Pulmonary Surfactant-Associated Protein D / immunology
  • Pulmonary Surfactant-Associated Protein D / metabolism
  • Sialyltransferases / genetics
  • Sialyltransferases / immunology
  • Sialyltransferases / metabolism
  • Signal Transduction
  • Transplantation, Heterologous / adverse effects*
  • Treatment Outcome
  • beta-D-Galactoside alpha 2-6-Sialyltransferase

Substances

  • CD47 Antigen
  • CD47 protein, human
  • Histocompatibility Antigens Class I
  • Pulmonary Surfactant-Associated Protein D
  • Sialyltransferases
  • beta-D-Galactoside alpha 2-6-Sialyltransferase